Presented by: Christoph Fürweger, Ph.D., European CyberKnife Center, Munich, Germany
Monte Carlo secondary dose calculation has recently become available as a new option for plan quality assurance (QA). Practical utility and limitations are discussed based on results from our preclinical validation, sensitivity analysis and clinical experience from 300 patient plans.
- To learn about the principles of Monte Carlo secondary dose calculation for patient QA
- To understand its value and its limitations as part of a general QA framework
- To define meaningful action levels for Monte Carlo based plan QA